897 related articles for article (PubMed ID: 14983235)
21. The Differential Effect of Apyrase Treatment and hCD39 Overexpression on Chronic Renal Fibrosis After Ischemia-Reperfusion Injury.
Roberts V; Campbell DJ; Lu B; Chia J; Cowan PJ; Dwyer KM
Transplantation; 2017 Jul; 101(7):e194-e204. PubMed ID: 28198766
[TBL] [Abstract][Full Text] [Related]
22. Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury.
Grenz A; Zhang H; Hermes M; Eckle T; Klingel K; Huang DY; Müller CE; Robson SC; Osswald H; Eltzschig HK
FASEB J; 2007 Sep; 21(11):2863-73. PubMed ID: 17442731
[TBL] [Abstract][Full Text] [Related]
23. Analysis of CD39/ATP diphosphohydrolase (ATPDase) expression in endothelial cells, platelets and leukocytes.
Koziak K; Sévigny J; Robson SC; Siegel JB; Kaczmarek E
Thromb Haemost; 1999 Nov; 82(5):1538-44. PubMed ID: 10595651
[TBL] [Abstract][Full Text] [Related]
24. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs.
Reutershan J; Vollmer I; Stark S; Wagner R; Ngamsri KC; Eltzschig HK
FASEB J; 2009 Feb; 23(2):473-82. PubMed ID: 18838482
[TBL] [Abstract][Full Text] [Related]
25. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
Covarrubias R; Chepurko E; Reynolds A; Huttinger ZM; Huttinger R; Stanfill K; Wheeler DG; Novitskaya T; Robson SC; Dwyer KM; Cowan PJ; Gumina RJ
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1809-20. PubMed ID: 27417582
[TBL] [Abstract][Full Text] [Related]
26. Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis.
Glenn JR; White AE; Johnson AJ; Fox SC; Myers B; Heptinstall S
Platelets; 2008 Feb; 19(1):59-69. PubMed ID: 18231939
[TBL] [Abstract][Full Text] [Related]
27. Targeted deletion of ectonucleoside triphosphate diphosphohydrolase 1/CD39 leads to desensitization of pre- and postsynaptic purinergic P2 receptors.
Schaefer U; Machida T; Broekman MJ; Marcus AJ; Levi R
J Pharmacol Exp Ther; 2007 Sep; 322(3):1269-77. PubMed ID: 17565006
[TBL] [Abstract][Full Text] [Related]
28. Reconstitution of CD39 in liposomes amplifies nucleoside triphosphate diphosphohydrolase activity and restores thromboregulatory properties.
Haller CA; Cui W; Wen J; Robson SC; Chaikof EL
J Vasc Surg; 2006 Apr; 43(4):816-23. PubMed ID: 16616242
[TBL] [Abstract][Full Text] [Related]
29. Development of a novel strategy to target CD39 antithrombotic activity to the endothelial-platelet microenvironment in kidney ischemia-reperfusion injury.
Sashindranath M; Dwyer KM; Dezfouli S; Selan C; Crikis S; Lu B; Yuan Y; Hickey MJ; Peter K; Robson SC; Cowan PJ; Nandurkar HH
Purinergic Signal; 2017 Jun; 13(2):259-265. PubMed ID: 28343356
[TBL] [Abstract][Full Text] [Related]
30. SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning.
Hart ML; Gorzolla IC; Schittenhelm J; Robson SC; Eltzschig HK
J Immunol; 2010 Apr; 184(7):4017-24. PubMed ID: 20207994
[TBL] [Abstract][Full Text] [Related]
31. Ectonucleoside triphosphate diphosphohydrolase 1/CD39, localized in neurons of human and porcine heart, modulates ATP-induced norepinephrine exocytosis.
Machida T; Heerdt PM; Reid AC; Schäfer U; Silver RB; Broekman MJ; Marcus AJ; Levi R
J Pharmacol Exp Ther; 2005 May; 313(2):570-7. PubMed ID: 15647328
[TBL] [Abstract][Full Text] [Related]
32. Visceral ischemia-reperfusion injury promotes tumor necrosis factor (TNF) and interleukin-1 (IL-1) dependent organ injury in the mouse.
Welborn MB; Douglas WG; Abouhamze Z; Auffenburg T; Abouhamze AS; Baumhofer J; Seeger JM; Pruitt JH; Edwards PD; Chizzonite R; Martin D; Moldawer LL; Harward TR
Shock; 1996 Sep; 6(3):171-6. PubMed ID: 8885081
[TBL] [Abstract][Full Text] [Related]
33. Genomic-independent action of thyroid hormones on NTPDase activities in Sertoli cell cultures from congenital hypothyroid rats.
Zamoner A; Bruno AN; Casali EA; Corbelini PF; Diniz GP; Barreto-Chaves ML; Silva FR; Sarkis JJ; Pessoa-Pureur R
Life Sci; 2006 Dec; 80(1):51-8. PubMed ID: 16978660
[TBL] [Abstract][Full Text] [Related]
34. Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice.
Beldi G; Banz Y; Kroemer A; Sun X; Wu Y; Graubardt N; Rellstab A; Nowak M; Enjyoji K; Li X; Junger WG; Candinas D; Robson SC
Hepatology; 2010 May; 51(5):1702-11. PubMed ID: 20146261
[TBL] [Abstract][Full Text] [Related]
35. Endogenous IL-13 protects hepatocytes and vascular endothelial cells during ischemia/reperfusion injury.
Kato A; Okaya T; Lentsch AB
Hepatology; 2003 Feb; 37(2):304-12. PubMed ID: 12540780
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39.
Gayle RB; Maliszewski CR; Gimpel SD; Schoenborn MA; Caspary RG; Richards C; Brasel K; Price V; Drosopoulos JH; Islam N; Alyonycheva TN; Broekman MJ; Marcus AJ
J Clin Invest; 1998 May; 101(9):1851-9. PubMed ID: 9576748
[TBL] [Abstract][Full Text] [Related]
37. Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction.
Day YJ; Marshall MA; Huang L; McDuffie MJ; Okusa MD; Linden J
Am J Physiol Gastrointest Liver Physiol; 2004 Feb; 286(2):G285-93. PubMed ID: 14715520
[TBL] [Abstract][Full Text] [Related]
38. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation.
Dwyer KM; Robson SC; Nandurkar HH; Campbell DJ; Gock H; Murray-Segal LJ; Fisicaro N; Mysore TB; Kaczmarek E; Cowan PJ; d'Apice AJ
J Clin Invest; 2004 May; 113(10):1440-6. PubMed ID: 15146241
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin II type 1 receptors and the intestinal microvascular dysfunction induced by ischemia and reperfusion.
Petnehazy T; Cooper D; Stokes KY; Russell J; Wood KC; Granger DN
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1203-10. PubMed ID: 16469824
[TBL] [Abstract][Full Text] [Related]
40. Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice.
Teoh NC; Ito Y; Field J; Bethea NW; Amr D; McCuskey MK; McCuskey RS; Farrell GC; Allison AC
Gastroenterology; 2007 Aug; 133(2):632-46. PubMed ID: 17681182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
